Pricing Log in Create free account

LB Pharmaceuticals Inc (LBRX) vs Silence Therapeutics PLC Sponsored ADR (SLN)

LB Pharmaceuticals Inc and Silence Therapeutics PLC Sponsored ADR are both Biotechnology companies. LB Pharmaceuticals Inc and Silence Therapeutics PLC Sponsored ADR are of similar size ($1.2B and $1.2B). Across the 9 metrics below, Silence Therapeutics PLC Sponsored ADR leads on 5 and LB Pharmaceuticals Inc on 4.

Valuation

Metric LBRX SLN Biotechnology median
P/E n/m n/m 10.60
P/S n/m 1,110.83 9.40
P/B 3.81 24.23 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1,025.03 9.02
Earnings yield (8.19%) (6.49%) (32.88%)
Free cash flow yield (6.54%) (4.54%) (23.13%)

Profitability

Metric LBRX SLN Biotechnology median
Gross margin — 79.50% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (72.07%) (90.41%) (51.96%)
Return on assets (47.38%) (44.14%) (46.06%)
Return on invested capital (1,304.79%) 0.00% 0.00%

Growth

Metric LBRX SLN Biotechnology median
Revenue growth (TTM) — (96.97%) 6.76%
EPS growth (last fiscal year) 98.22% (90.91%) 29.88%
Revenue growth, 5-year CAGR — (39.74%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LBRX SLN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.08 7.42 4.97
Net debt to EBITDA 9.90 0.94 1.01

Dividend

Metric LBRX SLN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LBRX SLN Biotechnology median
Market cap 1.23b 1.23b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack